November 15, 2017 09:27 AM EST
Pharma

Alk­er­mes touts equal ef­fi­ca­cy of month­ly Viv­it­rol against dai­ly Sub­ox­one

Brittany Meiling

A new study com­par­ing two of the main drugs treat­ing opi­oid ad­dic­tion found that the med­i­cines worked sim­i­lar­ly in help­ing pa­tients quit hero­in and oth­er …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

RFK Jr. and Elon Musk want to ban phar­ma ads. They would­n't be the first to try

Jazz wins ap­proval for bis­pe­cif­ic in bil­iary tract can­cer

No­var­tis seeks more bolt-on deals as it pur­chas­es neu­ro start­up for up to $1.1B

At Jef­feries, all that man­u­fac­tur­ers want to talk about is GLP-1s

FDA ad­comm rais­es risk ques­tions on As­traZeneca’s An­dexxa

sponsored

Are pro­grams with com­pound­ed GLP-1s safe for your pop­u­la­tion?

A service from the Financial Times